Overexpression of high molecular weight FGF-2 forms inhibits glioma growth by acting on cell-cycle progression and protein translation.

Abstract : In order to clarify the role of HMW FGF-2 in glioma development and angiogenesis, we over-expressed different human FGF-2 isoforms in C6 rat glioma cell line using a tetracycline-regulated expression system. Phenotypic modifications were analyzed in vitro and compared to untransfected cells or to cells over-expressing 18 kDa FGF-2 or all FGF-2 isoforms. In particular, we demonstrate that HMW FGF-2 has unique features in inhibiting glioma cell proliferation. HMW FGF-2 expressing cells showed a cell-cycle arrest at the G2M, demonstrating a role of HMW FGF-2 in controlling the entry in mitosis. Moreover, hydroxyurea was ineffective in blocking cells at the G1S boundary when HMW FGF-2 was expressed. We also show that the HMW FGF-2 isoforms inhibit 4E-BP1 phosphorylation at critical sites restoring the translation inhibitory activity of 4E-BP1. In vivo, inhibition of tumor growth was observed when cells expressed HMW FGF-2. This indicates that HMW FGF-2 inhibits tumor growth in glioma cells by acting on cell-cycle progression and protein translation.
Type de document :
Article dans une revue
Experimental Cell Research, Elsevier, 2008, 314 (20), pp.3701-11. 〈10.1016/j.yexcr.2008.09.022〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00409173
Contributeur : Marie Francoise Simon <>
Soumis le : jeudi 6 août 2009 - 13:27:53
Dernière modification le : mercredi 7 février 2018 - 14:52:02

Identifiants

Collections

Citation

Sylvie Lemiere, Rania Azar, Francis Belloc, Demir Gürsel, Stéphane Pyronnet, et al.. Overexpression of high molecular weight FGF-2 forms inhibits glioma growth by acting on cell-cycle progression and protein translation.. Experimental Cell Research, Elsevier, 2008, 314 (20), pp.3701-11. 〈10.1016/j.yexcr.2008.09.022〉. 〈inserm-00409173〉

Partager

Métriques

Consultations de la notice

175